Minko
Anatoly A. Minko, Minsk BY
Patent application number | Description | Published |
---|---|---|
20090027610 | The liquid crystal display with wide viewing angle and method for making it - The present invention relates generally to the field of electronics and may be used for making displays and, in particular, liquid crystal information displays, panels, cells e.t.c. | 01-29-2009 |
20110069268 | LIQUID CRYSTAL DISPLAY WITH WIDE VIEWING ANGLE AND METHOD FOR MAKING IT - The present invention relates generally to the field of electronics and may be used for making displays and, in particular, liquid crystal information displays, panels, cells e.t.c. | 03-24-2011 |
Auxence Minko, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20130244447 | OXIDATION OF METALLIC FILMS - Methods for the aqueous oxidation of metallic films are described. For example, a film of hafnium metal on a silicon substrate can be oxidized to hafnium dioxide using hot deionized water. Methods for fabricating electrical components such as capacitors and field effect transistors using the oxidized metallic films are also described. For example, capacitors having a hafnium dioxide dielectric layer can be fabricated. | 09-19-2013 |
Bronislaw Jerzy Minko, Western Australia AU
Patent application number | Description | Published |
---|---|---|
20110017021 | LANCE FOR INJECTING SOLID MATERIAL INTO A VESSEL - A lance for injecting a solid material into a vessel, such as a direct smelting vessel for producing molten iron, is disclosed. The lance has a core tube assembly comprising a passageway for solid material. The core tube assembly has an inlet for receiving solid material at a rear end and an outlet for discharging material at a forward end. The core tube assembly comprises an outer tube of a structural material and an inner tube of a wear resistant material that are bonded together. A core tube assembly per se and a method of manufacturing the assembly are also disclosed | 01-27-2011 |
George Minko, Munchen DE
Patent application number | Description | Published |
---|---|---|
20110185645 | MOBILE BUILDING - Mobile building comprising a plurality of wall elements ( | 08-04-2011 |
Glenn Minko, Staten Island, NY US
Patent application number | Description | Published |
---|---|---|
20150194726 | RADIATING ELEMENT AND ENGINEERED MAGNETIC MATERIAL - Various embodiments are described that relate to a radiating element and an engineered magnetic material. In a communication environment a radiating element can be used to communicate information, such as to send signals. Various factors, including electromagnetic factors, can influence the performance of the radiating element. In one example, if the radiating element becomes too close to a ground plane, then performance of the radiating element can suffer. To counter negative effects of being too close to the ground plane an engineered magnetic material can be employed that causes the radiating element to perform better when relatively close to the ground plane. | 07-09-2015 |
Irina G. Minko, Portland, OR US
Patent application number | Description | Published |
---|---|---|
20110236507 | INHIBITION OF DNA POLYMERASES TO AUGMENT CHEMOTHERAPEUTIC AND ANTIMICROBIAL AGENTS - Disclosed herein is the identification of human DNA polymerase κ (pol κ) as the polymerase that mediates repair of DNA containing interstrand cros slinks (ICLs). The mechanism of action of a number of chemotherapeutic and antimicrobial agents is the induction of ICLs. Thus, provided herein is a method of enhancing the efficacy of a chemotherapeutic or antimicrobial agent in a subject, including selecting a subject in need of treatment with an ICL-inducing agent and administering to the subject an ICL-inducing agent and a therapeutically effective amount of an inhibitor of pol κ. Subjects in need of treatment with an ICL-inducing agent, include, for example, subjects diagnosed with a hyperproliferative disease, an autoimmune disease or an infectious disease. Also provided is a composition for treating a hyperproliferative disease, an autoimmune disease or an infectious disease, comprising an ICL-inducing agent and an amount of an inhibitor of pol κ sufficient to enhance the efficacy of the ICL-inducing agent. Further provided is a method of identifying a DNA polymerase inhibitor. | 09-29-2011 |
Jacek Tomasz Minko, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20120155620 | Personal-Call and Feature Control System and Method for Controlling Telephones, Providing Extended Features for Such Telephones and Routing of Media-Rich Calls - A Personal-CFC system and method is described for controlling a multiplicity of telephones, for providing extended feature sets globally to all such telephones and for routing of media-rich calls between such telephones and multimedia equipment. The Personal-CFC is a software program that is easily embedded in various devices and it requires no hardware. For example, a mobile Personal-CFC system can be incorporated into a PDA or PC. The end user can use the Personal-CFC system to control other telephones, such as conference telephones, that do not belong to the end user. | 06-21-2012 |
Peter Minko, Schwelm DE
Patent application number | Description | Published |
---|---|---|
20120252963 | POWDER COATING METHOD - The invention relates to a powder coating method comprising the following steps: | 10-04-2012 |
Sergiy Minko, Potsdam, NY US
Patent application number | Description | Published |
---|---|---|
20090252691 | FOAM MANIPULATION COMPOSITIONS CONTAINING FINE PARTICLES - A foam manipulation stabilizing composition for use in consumer products includes a plurality of surface-modified particles in combination with at least one surfactant. The particles have an average particle size greater than 100 nm up to about 50 μm and a hydrophobicity measured by a contact angle between about 20° to 140°. The ratio of particles-to-surfactant may be between about 1:20 to about 20:1. The surface modification may include grafting pH or temperature switching functional groups to the particles or to a composition, such as a polymer, coated on the particle. A method for reducing the level of foam in a rinse solution is also described. | 10-08-2009 |
Sergiy Minko, Athens, GA US
Patent application number | Description | Published |
---|---|---|
20150345048 | MAGNETOSPINNING APPARATUS AND METHODS OF USE - Embodiments of the present disclosure provide magneto-spinning apparatus, methods of use, magnetospun material (e.g., a fiber such as a magnetic fiber), and the like. | 12-03-2015 |
20150345049 | MAGNETOSPINNING APPARATUS FOR LOW-MAGNETIC MATERIALS AND METHODS OF USE - Embodiments of the present disclosure provide magneto-spinning apparatus, methods of use, magnetospun material (e.g., a fiber such as a low- or non-magnetic fiber), and the like. | 12-03-2015 |
Tamara Minko, Somerset, NJ US
Patent application number | Description | Published |
---|---|---|
20120093919 | E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER - The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided. | 04-19-2012 |
20130273164 | NANOTECHNOLOGY APPROACH FOR INHALATION THERAPIES - This invention relates to lipid nanoparticle compositions and methods for the localized delivery of active agents via inhalation therapy. | 10-17-2013 |
20130302257 | Compositions and Methods for Delivering Nucleic Acid Molecules and Treating Cancer - The present invention provides compositions and methods for the delivery of nucleic acids to a cell. The present invention additionally provides compositions and methods for the treatment of a disease or disorder, particularly cancer. | 11-14-2013 |
Tamara Minko, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20080280813 | COMPLEX DRUG DELIVERY COMPOSITION AND METHOD FOR TREATING CANCER - The present invention relates to compositions and methods for producing a complex drug delivery system which specifically targets cancer cells, has an increase in cellular uptake, is cytotoxic, and suppresses antiapoptotic cellular defenses. | 11-13-2008 |
20110087004 | ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGNOSTIC AGENTS - The invention is directed to pharmaceutical compositions and methods for delivery of a therapeutic or diagnostic agent from one bodily compartment to one or more other bodily compartment by administering one of the following conjugates: a polymer having multiple functional groups at least one of which is covalently bound to a therapeutic or diagnostic agent, and at least one cell uptake promoter covalently bound to the therapeutic or diagnostic agent; or a polymer and at least one cell uptake promoter bound thereto; the polymer further comprising multiple functional groups at least one of which is covalently bound a therapeutic or diagnostic agent. | 04-14-2011 |
20130072447 | ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGANOSTIC AGENTS - The invention is directed to pharmaceutical compositions and methods for delivery of a therapeutic or diagnostic agent from one bodily compartment to one or more other bodily compartment by administering one of the following conjugates: a polymer having multiple functional groups at least one of which is covalently bound to a therapeutic or diagnostic agent, and at least one cell uptake promoter covalently bound to the therapeutic or diagnostic agent; or a polymer and at least one cell uptake promoter bound thereto; the polymer further comprising multiple functional groups at least one of which is covalently bound a therapeutic or diagnostic agent. | 03-21-2013 |
20150202248 | E2F AS A TARGET OF HORMONE REFRACTORY PROSTATE CANCER - The instant invention provides amino acid sequences competing with E2F for DNA binding. Methods of using said amino acid sequences for treatment of hormone-refractory prostate cancer are also provided. | 07-23-2015 |